BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6184617)

  • 1. Modulation of human NK cells by interferon and prostaglandin E2.
    Koren HS; Leung KH
    Mol Immunol; 1982 Oct; 19(10):1341-6. PubMed ID: 6184617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of human natural killing. I. The role of monocytes, interferon, and prostaglandins.
    Koren HS; Anderson SJ; Fischer DG; Copeland CS; Jensen PJ
    J Immunol; 1981 Nov; 127(5):2007-13. PubMed ID: 6170683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of human natural killing. III. Mechanism for interferon induction of loss of susceptibility to suppression by cyclic AMP elevating agents.
    Leung KH; Koren HS
    J Immunol; 1984 Mar; 132(3):1445-50. PubMed ID: 6319493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of monocytes in the augmentation of human natural killer cell activity by interleukin-2.
    Suzuki H; Yamashita N; Sugiyama E; Sato M; Ito M; Yano S
    Anticancer Res; 1984; 4(1-2):63-7. PubMed ID: 6608916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancer.
    Baxevanis CN; Reclos GJ; Gritzapis AD; Dedousis GV; Missitzis I; Papamichail M
    Cancer; 1993 Jul; 72(2):491-501. PubMed ID: 8319179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of NK cell activity by prostaglandin E2: the role of T cells.
    Zielinski CC; Gisinger C; Binder C; Mannhalter JW; Eibl MM
    Cell Immunol; 1984 Aug; 87(1):65-72. PubMed ID: 6611214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of human natural killing. II. Protective effect of interferon on NK cells from suppression by PGE2.
    Leung KH; Koren HS
    J Immunol; 1982 Oct; 129(4):1742-7. PubMed ID: 6180022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indomethacin therapy abrogates the prostaglandin-mediated suppression of natural killer activity in tumor-bearing mice and prevents tumor metastasis.
    Lala PK; Parhar RS; Singh P
    Cell Immunol; 1986 Apr; 99(1):108-18. PubMed ID: 2944621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relative resistance of lymphokine activated killer cells to suppression by prostaglandins and glucocorticoids.
    Imir T; Sibbitt W; Bankhurst A
    Prostaglandins Leukot Med; 1987 Jul; 28(2):111-8. PubMed ID: 3498171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The regulatory effects of monocytes on human natural killer cells activated by lipopolysaccharides.
    Lindemann RA
    J Periodontal Res; 1991 Nov; 26(6):486-90. PubMed ID: 1837053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular immunosenescence in F344 rats: decreased natural killer (NK) cell activity involves changes in regulatory interactions between NK cells, interferon, prostaglandin and macrophages.
    Bash JA; Vogel D
    Mech Ageing Dev; 1984 Jan; 24(1):49-65. PubMed ID: 6198565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin E2-mediated inactivation of various killer lineage cells by tumor-bearing host macrophages.
    Parhar RS; Lala PK
    J Leukoc Biol; 1988 Dec; 44(6):474-84. PubMed ID: 2973508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased natural killer cell activity in atopic eczema.
    Hall TJ; Rycroft R; Brostoff J
    Immunology; 1985 Oct; 56(2):337-44. PubMed ID: 3876984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dual interaction of prostaglandin E2 (PGE2) and interferon (IFN) on NK lytic activation: enhanced capacity of effector-target lytic interactions (recycling) and blockage of pre-NK cell recruitment.
    Targan SR
    J Immunol; 1981 Oct; 127(4):1424-8. PubMed ID: 6168691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural cytotoxicity of human blood lymphocytes and monocytes and their cytotoxic factors: effect of interferon on target cell susceptibility.
    Uchida A; Vánky F; Klein E
    J Natl Cancer Inst; 1985 Nov; 75(5):849-57. PubMed ID: 2414505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin E2-induced changes in the phenotype, morphology, and lytic activity of IL-2-activated natural killer cells.
    Linnemeyer PA; Pollack SB
    J Immunol; 1993 May; 150(9):3747-54. PubMed ID: 8386202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin-mediated inactivation of natural killer cells in the murine decidua.
    Scodras JM; Parhar RS; Kennedy TG; Lala PK
    Cell Immunol; 1990 May; 127(2):352-67. PubMed ID: 2139365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin E2, monocyte adherence and interleukin-1 in the regulation of human natural killer cell activity by monocytes.
    Bloom ET; Babbitt JT
    Nat Immun Cell Growth Regul; 1990; 9(1):36-48. PubMed ID: 2139495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression by alpha-fetoprotein of murine natural killer cell activity stimulated in vitro and in vivo by interferon and interleukin 2.
    Cohen BL; Orn A; Gronvik KO; Gidlund M; Wigzell H; Murgita RA
    Scand J Immunol; 1986 Feb; 23(2):211-23. PubMed ID: 2419966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of natural killer cell activity in mice by injection of indomethacin.
    Voth R; Chmielarczyk W; Storch E; Kirchner H
    Nat Immun Cell Growth Regul; 1986; 5(6):317-24. PubMed ID: 2432415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.